Obstructive Sleep Apnea (OSA), Oral Frailty, Dysphagia, Continuous Positive Airway Pressure (CPAP)

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Jul 28, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a treatment called Continuous Positive Airway Pressure (CPAP) affects people with obstructive sleep apnea (OSA), specifically focusing on issues like oral frailty (weakness in the mouth and jaw) and dysphagia (difficulty swallowing). If you are 50 years or older and have been diagnosed with OSA, this study might be a good fit for you. To qualify, you should have a certain level of sleep apnea and be able to communicate comfortably in Mandarin or Taiwanese.

Participants in this trial will be monitored to see how CPAP treatment impacts their oral health and swallowing abilities. It’s important to note that individuals with central sleep apnea, certain neurological or muscular disorders, or those currently receiving treatment for oral cancer will not be eligible to join. This study aims to find out if CPAP can help improve quality of life for those struggling with these related issues. If you think you might be interested, this could be an opportunity to contribute to important research while receiving support for your health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 50 years or older.
• • Medically diagnosed with obstructive sleep apnea (apnea and hypopnea index, AHI, ≥ 5 events per hour).
• • Clear consciousness and able to communicate in Mandarin or Taiwanese.
• Exclusion Criteria:
• • Central sleep apnea patients.
• • Patients with neurological or muscular disorders (such as stroke or Parkinson's disease).
• • Patients diagnosed with oral cancer currently undergoing oral treatment.